• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    FDA Approval for TOUJEO MAX SOLOSTAR issued to SANOFI US SERVICES

    8/30/24 9:33:45 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $SNY alert in real time by email
    Biologic License Application (BLA): 206538
    Company: SANOFI US SERVICES
    • Email
    • Summary Review
    • This Former NDA Was Deemed To Be a BLA on March 23, 2020.

    Products on BLA 206538

    Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
    TOUJEO MAX SOLOSTAR INSULIN GLARGINE RECOMBINANT 900 UNITS/3ML (300 UNITS/ML) SOLUTION;SUBCUTANEOUS Prescription None No No
    TOUJEO SOLOSTAR INSULIN GLARGINE RECOMBINANT 450 UNITS/1.5ML (300 UNITS/ML) SOLUTION;SUBCUTANEOUS Prescription None No No

    Approval Date(s) and History, Letters, Labels, Reviews for BLA 206538

    Original Approvals or Tentative Approvals
    Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
    02/25/2015 ORIG-1 Approval N/A Label (PDF)
    Letter (PDF)
    Review
    Summary Review (PDF)
    https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206538s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/206538Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206538Orig1s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206538Orig1s000SumR.pdf
    Supplements
    Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
    08/29/2024 SUPPL-17 Supplement Label (PDF)
    Letter (PDF)
    https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206538Orig1s017Lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/206538Orig1s017ltr.pdf
    08/16/2022 SUPPL-16 Supplement Label (PDF)
    Letter (PDF)
    https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206538s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/206538Orig1s016ltr.pdf
    11/15/2019 SUPPL-14 Supplement Label (PDF)
    Letter (PDF)
    https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206538s013s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021081Orig1s073, s074; 021629Orig1s039, s040; 206538Orig1s013, s014ltr.pdf
    11/15/2019 SUPPL-13 Supplement Label (PDF)
    Letter (PDF)
    https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206538s013s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021081Orig1s073, s074; 021629Orig1s039, s040; 206538Orig1s013, s014ltr.pdf
    11/26/2019 SUPPL-12 Supplement Label (PDF)
    Label (PDF)
    https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/206538Orig1s012ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206538s012lbl.pdf
    10/25/2018 SUPPL-11 Supplement Label (PDF)
    https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206538s010s011lbl.pdf
    10/25/2018 SUPPL-10 Supplement Label (PDF)
    https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206538s010s011lbl.pdf
    03/26/2018 SUPPL-6 Supplement Label (PDF)
    Letter (PDF)
    https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206538s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/206538Orig1s006ltr.pdf
    11/23/2016 SUPPL-3 Supplement

    Label is not available on this site.

    02/16/2016 SUPPL-2 Supplement

    Label is not available on this site.

    09/29/2015 SUPPL-1 Supplement Letter (PDF)

    Label is not available on this site.

    https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206538s001lbl.pdf

    Labels for BLA 206538

    Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
    Patient Package Insert
    Note Url
    08/29/2024 SUPPL-17 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/206538Orig1s017Lbl.pdf
    08/16/2022 SUPPL-16 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206538s016lbl.pdf
    08/16/2022 SUPPL-16 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/206538s016lbl.pdf
    11/26/2019 SUPPL-12 Efficacy-New Patient Population Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/206538Orig1s012ltr.pdf
    11/26/2019 SUPPL-12 Efficacy-New Patient Population Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206538s012lbl.pdf
    11/15/2019 SUPPL-14 Labeling-Patient Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206538s013s014lbl.pdf
    11/15/2019 SUPPL-14 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206538s013s014lbl.pdf
    11/15/2019 SUPPL-13 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206538s013s014lbl.pdf
    11/15/2019 SUPPL-13 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206538s013s014lbl.pdf
    10/25/2018 SUPPL-11 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206538s010s011lbl.pdf
    10/25/2018 SUPPL-11 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206538s010s011lbl.pdf
    10/25/2018 SUPPL-10 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206538s010s011lbl.pdf
    03/26/2018 SUPPL-6 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206538s006lbl.pdf
    03/26/2018 SUPPL-6 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206538s006lbl.pdf
    03/26/2018 SUPPL-6 Labeling-Patient Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206538s006lbl.pdf
    02/25/2015 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206538s000lbl.pdf
    Get the next $SNY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SNY

    DatePrice TargetRatingAnalyst
    4/15/2025$65.00Outperform
    Exane BNP Paribas
    3/21/2025$65.00Neutral
    Goldman
    1/30/2025Sell → Hold
    Deutsche Bank
    7/26/2024$55.00 → $60.00Buy
    Argus
    1/23/2024$55.00Equal-Weight
    Morgan Stanley
    1/16/2024Buy
    UBS
    12/5/2023Overweight → Neutral
    JP Morgan
    10/30/2023Buy → Hold
    Stifel
    More analyst ratings

    $SNY
    SEC Filings

    See more
    • SEC Form 11-K filed by Sanofi

      11-K - Sanofi (0001121404) (Filer)

      6/27/25 4:52:49 PM ET
      $SNY
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 11-K filed by Sanofi

      11-K - Sanofi (0001121404) (Filer)

      6/27/25 4:49:46 PM ET
      $SNY
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 6-K filed by Sanofi

      6-K - Sanofi (0001121404) (Filer)

      6/24/25 8:31:04 AM ET
      $SNY
      Biotechnology: Pharmaceutical Preparations
      Health Care